Browse our anti-Cathepsin H (CTSH) Antibodies

Human Cathepsin H (CTSH) interaction partners

1. the up-regulation of MMP genes is mediated through degradation of class IIa histone deacetylases (HDACs) by certain cysteine cathepsins (Cts (show TTR Antibodies)).

2. Especially, rs3825932 in CTSH has integrative functional evidence supporting the association with type 1 diabetes mellitus.

3. p41 (show EPB41 Antibodies) fragment is also shown to reduce the secretion of interleukin-12 (IL-12 (show IL12A Antibodies)/p70 (show ANXA6 Antibodies)) during the subsequent maturation of treated dendritic cells.

4. In conclusion, CTSH/rs3825932 and ERBB3 (show ERBB3 Antibodies)/rs2292239 SNPs were associated with reduced risk of progression to proliferative diabetic retinopathy and two-step progression of diabetic retinopathy on the ETDRS scale accordingly.

5. mutation in LRPAP1 is associated with high myopia. Further studies are expected to evaluate the pathogenicity of the variants in CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2.

6. The data provide strong evidence that CTSH is an important regulator of beta-cell function during progression of T1D

7. Quantification of immunohistochemistry showed that there is no difference in the global expression of CTSD (show CTSD Antibodies), CTSH and CTSK (show CTSK Antibodies) between asthmatics and non-asthmatics.

8. CtsH-mediated processing of talin might promote cancer cell progression by affecting integrin alphaVbeta3 (show ITGAV Antibodies) activation and adhesion strength

9. The processing of procathepsin H is an autocatalytic, multistep process proceeding from an inactive 41kDa pro-form, through a 30kDa (show SAP30 Antibodies) intermediate form, to the 28kDa mature form.

10. CTSH overexpression in a subset hepatoma may be thyroid hormone receptor (show THRA Antibodies) dependent and suggests that this overexpression has an important role in hepatoma progression.

Mouse (Murine) Cathepsin H (CTSH) interaction partners

1. CatH deficiency impaired toll-like receptor 3 (show TLR3 Antibodies)-mediated activation of interferon regulatory factor 3 (show IRF3 Antibodies) and consequent secretion of IFN-beta (show IFNB1 Antibodies)

2. The data provide strong evidence that CTSH is an important regulator of beta-cell function during progression of T1D

3. Cathepsin H knockout mice show reduced brain levels of (Met)enkephalin and galanin (show GAL Antibodies).

4. cathepsin H is involved in the SP-B production.

5. CTSH overexpression in a subset hepatoma may be thyroid hormone receptor (show THRA Antibodies) dependent and suggests that this overexpression has an important role in hepatoma progression.

6. In two mouse models of pancreatic islet cancer, deletion of CtsH reduced tumor progression; mechanisms involved impaired angiogenic switching from premalignant state, poor vascularization of tumors, and increased apoptosis.

7. In proteolipid protein transgenic mice cathepsin H is upregulated primarily in microglia/macrophages of white matter.

8. Presence of cathepsin H and (bone morphogenetic protein 4)BMP4 (show BMP4 Antibodies) in lung or other developing organs suggest that cathepsin H regulates BMP4 (show BMP4 Antibodies) proteolysis in morphogenesis.